Remdesivir

Remdesivir binds to the RNA polymerase enzyme, an enzyme that helps the coronavirus to replicate itself. This inhibits viral replication by premature termination of RNA transcription. Thereby, Remdesivir lowers the virus load in the body and helps treat the infection.

Remdesivir should not be taken along with chloroquine phosphate and hydroxychloroquine sulphate as it might cause reduced anti-viral activity of Remdesivir. Co-administration of these drugs is not recommended.

No, Remdesivir is not indicated for the prevention of coronavirus disease. Remdesivir has been approved by DCGI (Drug Control General of India) for emergency use only in patients who are COVID-positive.

Regularly clean your hands thoroughly using soap and water or an alcohol-based sanitiser. Avoid touching your nose, eyes, and mouth without washing your hands. Clean and disinfect surfaces regularly. Always remember to wear a mask, maintain social distance and avoid gatherings.

Covid-19 spreads through respiratory droplets when in close or direct contact with an infected person. The virus can spread through an infected person’s sneeze or cough. The virus can also be transmitted by touching any contaminated surfaces and then touching the nose, mouth or eyes without washing the hands.

Remdesivir belongs to a group of anti-viral medicines called SARS-CoV-2 nucleotide analogue RNA polymerase inhibitor used to treat coronavirus disease requiring hospitalisation.

Inform your doctor, if you are allergic to any of its contents. If you have heart, liver or kidney problems or if you are using any other medications. And also let your doctor know if you are breastfeeding, pregnancy or planning pregnancy before starting Remdesivir to avoid possible interactions.

Not every patient with COVID-19 requires Remdesivir. It is specifically recommended for adults and children hospitalized with severe COVID-19 who require oxygen therapy or are on a ventilator. However, always consult your doctor for personalized medical advice.

COVID-19 is a respiratory illness caused by the SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2) virus. The common symptoms of corona virus disease are dry cough, breathlessness, shortness of breath, tiredness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache and sore throat.

An Emergency Use Authorization (EUA) is a mechanism used by the U.S. food and drug administration (FDA) to expedite the availability and use of medical products, such as drugs and vaccines, during public health emergencies. EUA's are typically issued during situations like the COVID-19 pandemic to quickly provide access to critical medical countermeasures.

Remdesivir is administered intravenously (IV), by a healthcare professional in a hospital or healthcare setting. Do not self-administer.

Remdesivir is used to treat hospitalized patients who are suffering with severe COVID-19.

The common side effects of Remdesivir are nausea, increased transaminase levels and increased prothrombin time. If any of these side effects persist or worsen, please consult your doctor.

Yes, Remdesivir is generally considered safe when used under the supervision of a healthcare professional. However, like all medications, it can have side effects. So it's important to monitor for any adverse reactions and inform your doctor if you any side effects persist or worsen.

A pregnant women infected with covid-19 should take the advice of a doctor as there is limited data on the safety of Remdesivir during pregnancy.

If you are suffering from diabetes and high blood pressure, you should take your doctor’s advice before taking Remdesivir.

Remdesivir should only be administered to those with laboratory-confirmed COVID-19 infection to ensure its appropriate use and effectiveness. However, consult your doctor, if you are highly suspected with COVID -19 symptoms.